Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico

Background: Acute variceal bleeding in cirrhotic patients is an emergency with a high risk of rebleeding and death. Endoscopic procedures such as sclerotherapy or banding, combined or not with drugs such as octreotide could be considered. Aim: To assess the value of octreotide in the control of acut...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Silva P,Guillermo, Quera P,Rodrigo, Fluxá G,Fernando, Sanhueza B,Edgar, Segovia M,Roberto, Brahm B,Javier, Muñoz T,Cristián, Morales B,Antonio, Muñoz C,Lorena, Urzúa F,Luis, Biagini A,Leandro
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2004
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872004000300002
record_format dspace
spelling oai:scielo:S0034-988720040003000022004-12-13Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntricoSilva P,GuillermoQuera P,RodrigoFluxá G,FernandoSanhueza B,EdgarSegovia M,RobertoBrahm B,JavierMuñoz T,CristiánMorales B,AntonioMuñoz C,LorenaUrzúa F,LuisBiagini A,Leandro Esophageal and gastric varices Gastrointestinal hemorrhage Hypertension Octreotide Portal Background: Acute variceal bleeding in cirrhotic patients is an emergency with a high risk of rebleeding and death. Endoscopic procedures such as sclerotherapy or banding, combined or not with drugs such as octreotide could be considered. Aim: To assess the value of octreotide in the control of acute variceal bleeding. Patients and methods: Ninety-two patients were randomized into three groups: endoscopic therapy plus octreotide 50 µg/h bolus and continuous infusion for 5 days (n= 36); octreotide (same dosage) (n= 13) and endoscopic therapy only (banding and/or sclerotherapy) (n= 43). Results: Haemostasis at 24 hours was achieved in 97% of patients with combined treatment, 69% of patients receiving octreotide, and 93% of patients with endoscopic therapy (p= 0.2). Three patients with combined treatment, four patients receiving octreotide and eight patients with endoscopic therapy, rebled during the first five days (p= 0.15). The mean of blood units transfused was similar in the three groups. No differences were observed in hospital days and side effects. At 42 days of follow up, eight patients with endoscopic therapy, one patients with combined therapy and 2 patients receiving octreotide, died (p=NS). Conclusions: Octreotide is useful in the management of acute variceal bleeding. The absence of important side effects, renders it as a safe adjuvant treatment associated with endoscopic treatment (Rev Méd Chile 2004; 132: 285-94).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.132 n.3 20042004-03-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300002es10.4067/S0034-98872004000300002
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Esophageal and gastric varices
Gastrointestinal hemorrhage
Hypertension
Octreotide
Portal
spellingShingle Esophageal and gastric varices
Gastrointestinal hemorrhage
Hypertension
Octreotide
Portal
Silva P,Guillermo
Quera P,Rodrigo
Fluxá G,Fernando
Sanhueza B,Edgar
Segovia M,Roberto
Brahm B,Javier
Muñoz T,Cristián
Morales B,Antonio
Muñoz C,Lorena
Urzúa F,Luis
Biagini A,Leandro
Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico
description Background: Acute variceal bleeding in cirrhotic patients is an emergency with a high risk of rebleeding and death. Endoscopic procedures such as sclerotherapy or banding, combined or not with drugs such as octreotide could be considered. Aim: To assess the value of octreotide in the control of acute variceal bleeding. Patients and methods: Ninety-two patients were randomized into three groups: endoscopic therapy plus octreotide 50 µg/h bolus and continuous infusion for 5 days (n= 36); octreotide (same dosage) (n= 13) and endoscopic therapy only (banding and/or sclerotherapy) (n= 43). Results: Haemostasis at 24 hours was achieved in 97% of patients with combined treatment, 69% of patients receiving octreotide, and 93% of patients with endoscopic therapy (p= 0.2). Three patients with combined treatment, four patients receiving octreotide and eight patients with endoscopic therapy, rebled during the first five days (p= 0.15). The mean of blood units transfused was similar in the three groups. No differences were observed in hospital days and side effects. At 42 days of follow up, eight patients with endoscopic therapy, one patients with combined therapy and 2 patients receiving octreotide, died (p=NS). Conclusions: Octreotide is useful in the management of acute variceal bleeding. The absence of important side effects, renders it as a safe adjuvant treatment associated with endoscopic treatment (Rev Méd Chile 2004; 132: 285-94).
author Silva P,Guillermo
Quera P,Rodrigo
Fluxá G,Fernando
Sanhueza B,Edgar
Segovia M,Roberto
Brahm B,Javier
Muñoz T,Cristián
Morales B,Antonio
Muñoz C,Lorena
Urzúa F,Luis
Biagini A,Leandro
author_facet Silva P,Guillermo
Quera P,Rodrigo
Fluxá G,Fernando
Sanhueza B,Edgar
Segovia M,Roberto
Brahm B,Javier
Muñoz T,Cristián
Morales B,Antonio
Muñoz C,Lorena
Urzúa F,Luis
Biagini A,Leandro
author_sort Silva P,Guillermo
title Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico
title_short Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico
title_full Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico
title_fullStr Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico
title_full_unstemmed Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico
title_sort octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico
publisher Sociedad Médica de Santiago
publishDate 2004
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300002
work_keys_str_mv AT silvapguillermo octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT queraprodrigo octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT fluxagfernando octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT sanhuezabedgar octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT segoviamroberto octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT brahmbjavier octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT munoztcristian octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT moralesbantonio octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT munozclorena octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT urzuafluis octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
AT biaginialeandro octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico
_version_ 1718436138968940544